Note 4. Accounts Receivable

Accounts receivable consisted of the following components at June 30, 2019 and 2018:


	June 30,		June 30,
(In thousands)	2019		2018
Gross accounts receivable	$	361,323	$	503,175
Less Chargebacks reserve		(89,567)		(153,034)
Less Rebates reserve		(32,099)		(33,102)
Less Returns reserve		(55,554)		(43,059)
Less Other deductions		(18,128)		(20,021)
Less Allowance for doubtful accounts		(1,223)		(1,308)
Accounts receivable, net	$	164,752	$	252,651

For the fiscal year ended June 30, 2019, the Company recorded a provision for chargebacks, rebates, returns and other deductions of $1.0 billion, $250.6 million, $42.0 million and $67.3 million, respectively. For the fiscal year ended June 30, 2018, the Company recorded a provision for chargebacks, rebates, returns and other deductions of $1.1 billion, $296.8 million, $24.0 million and $69.9 million, respectively. For the fiscal year ended June 30, 2017, the Company recorded a provision for chargebacks, rebates, returns and other deductions of $881.3 million, $297.0 million, $25.4 million and $53.4 million, respectively.

The following table identifies the activity and ending balances of each major category of revenue-related reserve for fiscal years 2019, 2018 and 2017:


Reserve Category
(In thousands)	Chargebacks		Rebates		Returns		Other		Total
Balance at June 30, 2016	$	86,495	$	54,084	$	40,593	$	16,851	$	198,023
Additions related to the KUPI acquisition		—		8,329		5,955		—		14,284
Current period provision		881,283		297,050		25,416		53,398		1,257,147
Credits issued during the period		(888,241)		(271,847)		(29,829)		(59,153)		(1,249,070)
Balance at June 30, 2017		79,537		87,616		42,135		11,096		220,384
Current period provision		1,141,995		296,784		24,024		69,898		1,532,701
Credits issued during the period		(1,068,498)		(301,898)		(23,100)		(60,973)		(1,454,469)
Balance at June 30, 2018		153,034		82,502		43,059		20,021		298,616
Adjustment related to adoption of ASC 606		—		—		—		3,536		3,536
Current period provision		1,047,192		250,555		41,982		67,344		1,407,073
Credits issued during the period		(1,110,659)		(254,783)		(29,487)		(72,773)		(1,467,702)
Balance at June 30, 2019	$	89,567	$	78,274	$	55,554	$	18,128	$	241,523

For the fiscal years ended June 30, 2019, 2018 and 2017, as a percentage of gross sales the provision for chargebacks was 51.4%, 52.0% and 47.0%, respectively, the provision for rebates was 12.3%, 13.5% and 15.8%, respectively, the provision for returns was 2.1%, 1.1% and 1.4%, respectively and the provision for other adjustments was 3.3%, 3.2% and 2.8%, respectively.

On July 1, 2018, the Company adopted ASC 606 which resulted in a $3.2 million pre-tax adjustment to opening retained earnings and accounts receivable, of which $3.5 million related to “failure-to-supply” reserves offset by $0.3 million related to the timing of recognition of certain contract manufacturing arrangements.

The decrease in total reserves from June 30, 2018 to June 30, 2019 was primarily due to the expiration of the JSP Distribution Agreement, which resulted in lower Levothyroxine-related chargebacks at June 30, 2019 as compared to June 30, 2018. Increased customer orders in June 2018 in advance of a mid-week holiday as well as a related maintenance shutdown of the Company’s Seymour, Indiana manufacturing facility in the first week of July 2018 also contributed to the decrease in the chargebacks reserve. The activity in the “Other” category includes shelf-stock, shipping and other sales adjustments including prompt payment discounts and “failure-to-supply” adjustments. Historically, we have not recorded any material amounts in the current period related to reversals or additions of prior period reserves. If the Company were to record a material reversal or addition of any prior period reserve amount, it would be separately disclosed.